Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

Abstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is...

Full description

Bibliographic Details
Main Authors: Stein Harald Johnsen, Bjarne K. Jacobsen, Sigrid K. Brækkan, John-Bjarne Hansen, Ellisiv B. Mathiesen
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Nutrition Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12937-018-0364-8
_version_ 1817993514542170112
author Stein Harald Johnsen
Bjarne K. Jacobsen
Sigrid K. Brækkan
John-Bjarne Hansen
Ellisiv B. Mathiesen
author_facet Stein Harald Johnsen
Bjarne K. Jacobsen
Sigrid K. Brækkan
John-Bjarne Hansen
Ellisiv B. Mathiesen
author_sort Stein Harald Johnsen
collection DOAJ
description Abstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is associated with reduced plaque size. Methods We obtained questionnaire-based information on fish consumption and carotid ultrasonography from 3900 persons aged 45–74 years. The questionnaires were validated by measuring serum concentrations of PUFAs and triglycerides in a subgroup. At follow-up seven years later, 2983 (76%) went through a second ultrasound scanning. Logistic regression and general linear models were used to analyze the outcome (plaque presence and plaque area) as a function of fish consumption, including analyses stratified on fish oil supplements. Results At baseline, lean fish intake < 1 time/week vs. 1–1.9 times/week was associated with risk of plaque (OR 1.34, 95% CI 1.03–1.76). Fatty fish intake and use of fish oil supplements were not statistically significantly associated with atherosclerosis at baseline. In persons without plaque at baseline, total fish consumption ≥3 times/week vs. 1–1.9 times/week was associated with risk of novel plaque (OR 1.32, 95% CI 1.01–1.73) and larger plaque area (1.76 mm2 vs. 1.46 mm2, p = 0.02) at follow-up. Adjustments for use of fish oil supplements had no impact on the associations, and no interactions were seen between total, fatty or lean fish consumption and fish oil intake. Conclusions We found no protective effect of fatty fish eating or fish oil supplements on atherosclerotic plaque formation or plaque area in a general population. Lean fish consumption was associated with a reduced risk for plaque in cross-sectional analysis, suggesting that the beneficial effects of fish consumption on atherosclerosis may be mediated through other mechanisms than n-3 PUFAs.
first_indexed 2024-04-14T01:39:57Z
format Article
id doaj.art-f2e82fd8a13f4027812839147db33e1c
institution Directory Open Access Journal
issn 1475-2891
language English
last_indexed 2024-04-14T01:39:57Z
publishDate 2018-05-01
publisher BMC
record_format Article
series Nutrition Journal
spelling doaj.art-f2e82fd8a13f4027812839147db33e1c2022-12-22T02:19:48ZengBMCNutrition Journal1475-28912018-05-011711910.1186/s12937-018-0364-8Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø studyStein Harald Johnsen0Bjarne K. Jacobsen1Sigrid K. Brækkan2John-Bjarne Hansen3Ellisiv B. Mathiesen4Department of Neurology, University Hospital of North NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayK. G. Jebsen TREC - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT The Arctic University of NorwayK. G. Jebsen TREC - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT The Arctic University of NorwayDepartment of Neurology, University Hospital of North NorwayAbstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is associated with reduced plaque size. Methods We obtained questionnaire-based information on fish consumption and carotid ultrasonography from 3900 persons aged 45–74 years. The questionnaires were validated by measuring serum concentrations of PUFAs and triglycerides in a subgroup. At follow-up seven years later, 2983 (76%) went through a second ultrasound scanning. Logistic regression and general linear models were used to analyze the outcome (plaque presence and plaque area) as a function of fish consumption, including analyses stratified on fish oil supplements. Results At baseline, lean fish intake < 1 time/week vs. 1–1.9 times/week was associated with risk of plaque (OR 1.34, 95% CI 1.03–1.76). Fatty fish intake and use of fish oil supplements were not statistically significantly associated with atherosclerosis at baseline. In persons without plaque at baseline, total fish consumption ≥3 times/week vs. 1–1.9 times/week was associated with risk of novel plaque (OR 1.32, 95% CI 1.01–1.73) and larger plaque area (1.76 mm2 vs. 1.46 mm2, p = 0.02) at follow-up. Adjustments for use of fish oil supplements had no impact on the associations, and no interactions were seen between total, fatty or lean fish consumption and fish oil intake. Conclusions We found no protective effect of fatty fish eating or fish oil supplements on atherosclerotic plaque formation or plaque area in a general population. Lean fish consumption was associated with a reduced risk for plaque in cross-sectional analysis, suggesting that the beneficial effects of fish consumption on atherosclerosis may be mediated through other mechanisms than n-3 PUFAs.http://link.springer.com/article/10.1186/s12937-018-0364-8AtherosclerosisFish consumptionPUFAsCarotid ultrasonographyFish oil
spellingShingle Stein Harald Johnsen
Bjarne K. Jacobsen
Sigrid K. Brækkan
John-Bjarne Hansen
Ellisiv B. Mathiesen
Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Nutrition Journal
Atherosclerosis
Fish consumption
PUFAs
Carotid ultrasonography
Fish oil
title Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
title_full Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
title_fullStr Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
title_full_unstemmed Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
title_short Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
title_sort fish consumption fish oil supplements and risk of atherosclerosis in the tromso study
topic Atherosclerosis
Fish consumption
PUFAs
Carotid ultrasonography
Fish oil
url http://link.springer.com/article/10.1186/s12937-018-0364-8
work_keys_str_mv AT steinharaldjohnsen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy
AT bjarnekjacobsen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy
AT sigridkbrækkan fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy
AT johnbjarnehansen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy
AT ellisivbmathiesen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy